Cargando…
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries
Background: Kinases represent potential therapeutic targets in pancreatic endocrine tumours (PETs). Patients and methods: Thirty-five kinase genes were sequenced in 36 primary PETs and three PET cell lines: (i) 4 receptor tyrosine kinases (RTK), epithelial growth factor receptor (EGFR), human epider...
Autores principales: | Corbo, V., Beghelli, S., Bersani, S., Antonello, D., Talamini, G., Brunelli, M., Capelli, P., Falconi, M., Scarpa, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276319/ https://www.ncbi.nlm.nih.gov/pubmed/21447618 http://dx.doi.org/10.1093/annonc/mdr048 |
Ejemplares similares
-
Chromosome 3p alterations in pancreatic endocrine neoplasia
por: Amato, Eliana, et al.
Publicado: (2010) -
Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis
por: Moore, P S, et al.
Publicado: (2001) -
Mutational Profiling of Kinases in Human Tumours of Pancreatic Origin Identifies Candidate Cancer Genes in Ductal and Ampulla of Vater Carcinomas
por: Corbo, Vincenzo, et al.
Publicado: (2010) -
Genetic abnormalities in pancreatic cancer
por: Moore, Patrick S, et al.
Publicado: (2003) -
A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer
por: Mercalli, A, et al.
Publicado: (2007)